Docusate Export Market Intelligence: India's 25 Suppliers Shipping to 35 Countries — TransData Nexus 2026

Q: Who are the top docusate exporters from India?

The top docusate exporters from India are: 1. TRUECARE BIOMEDIX — $5.9M (63.2% market share); 2. TRUE CARE BIOMEDIX — $1.2M (13.1% market share); 3. CIPLA LIMITED — $740.0K (8.0% market share); 4. SUNGLOW LIFESCIENCE PRIVATE LIMITED — $466.7K (5.0% market share); 5. ELYSIUM PHARMACEUTICALS LTD — $248.1K (2.7% market share). Together they account for 92.0% of India's total docusate export value.

Q: What is the total export value of docusate from India?

The total export value of docusate from India is $9.3M USD, recorded across 453 shipment transactions from 25 active exporters to 35 destination countries. The average shipment value is $20.5K.

Q: Which countries import docusate from India?

India exports docusate to 35 countries worldwide. The top importing countries are: UNITED STATES (84.6% share, $7.8M), AUSTRALIA (12.9% share, $1.2M), CANADA (1.5% share, $134.6K), VENEZUELA (0.3% share, $28.3K), NEW ZEALAND (0.2% share, $18.7K). These five markets account for 99.4% of total export value.

Q: What is the HS code for docusate exports from India?

The primary HS code for docusate exports from India is 30049039. This 8-digit classification falls under Chapter 30 (pharmaceutical products) of the Harmonized System and is used by Indian Customs (DGFT) for tracking and reporting pharmaceutical trade flows.

Q: What is the average price of docusate exports from India?

The average unit price for docusate exports from India is $12.69 USD per unit, with prices ranging from $0.00 to $283.62 depending on formulation, packaging, and order volume. The total market is valued at $9.3M across 453 shipments.

Q: Which ports handle docusate exports from India?

The primary ports for docusate exports from India are SAHAR AIR (17.4% of shipments), MUNDRA SEA (15.0% of shipments), MUNDRA SEA (INMUN1) (11.0% of shipments), SAHAR AIR CARGO ACC (INBOM4) (10.6% of shipments), Bombay Air (4.4% of shipments). These ports have dedicated pharmaceutical cargo infrastructure ensuring cold-chain and regulatory compliance during transit.

Q: Why is India a leading exporter of docusate?

India is one of the world's leading exporters of docusate due to its large base of 25 WHO-GMP and US FDA approved manufacturers, significantly lower production costs compared to Western markets, well-established API (Active Pharmaceutical Ingredient) supply chains, and strong government support for pharmaceutical exports through the Pharmaceuticals Export Promotion Council (Pharmexcil). India exports docusate to 35 countries, demonstrating 18% global market coverage.

Q: What certifications do Indian docusate exporters need?

Indian docusate exporters typically require WHO-GMP (Good Manufacturing Practice) certification for most regulated markets, US FDA approval for exports to the United States, EU GMP certification for European markets, and country-specific regulatory approvals for markets in Africa, Asia, and Latin America. Additional certifications may include ISO 9001, Schedule M compliance under Indian drug laws, and Free Sale Certificates issued by the Central Drugs Standard Control Organization (CDSCO).

Q: How many buyers import docusate from India?

There are 158 registered buyers importing docusate from India, spread across 35 countries. The repeat buyer rate is 27.2%, indicating strong long-term trade relationships and consistent product quality.

Q: What is the market share of the top docusate supplier from India?

TRUECARE BIOMEDIX is the leading docusate exporter from India with a market share of 63.2% and total export value of $5.9M across 136 shipments. The top 5 suppliers together control 92.0% of total export value.

Suresh Sormare

Docusate

India Pharmaceutical Trade Intelligence

$9.3M25 Suppliers35 CountriesHS 30049039

ExportsIndia → UNITED STATES84.6%India → AUSTRALIA12.9%

ImportsUNITED KINGDOM → India$324 JAPAN → India$71

#1 Supplier: TRUECARE BIOMEDIX #1 Buyer: PL DEVELOPMENTS

Docusate Export Analysis | India Pharmaceutical Trade Intelligence | TransData Nexus

How India Exports Docusate to the World

Between 2022 and 2026, India exported $9.3M worth of docusate across 453 verified shipments to 35 countries — covering 18% of world markets in the Gastrointestinal segment. The largest destination is UNITED STATES (84.6%). TRUECARE BIOMEDIX leads with a 63.2% share. All figures are drawn from Indian Customs (DGFT) shipping bill records spanning four years of trade activity.

Source: Indian Customs (DGFT)·Published March 2026·Updated March 2026·HS 30049039

Docusate export data from India — top exporters, importing countries, pricing and trade statistics compiled by TransData Nexus — Docusate export data snapshot — $9.3M · 25 exporters · 35 countriesTransData Nexus · Indian Customs Data

Top Docusate Exporters from India

25 active exporters · Ranked by export value

View all 25 →

Top Docusate Exporters from India — Ranked by Export Value
#	Supplier Name	Export Value (USD)	Shipments	Countries	Market Share
1	TRUECARE BIOMEDIX	$5.9M	136	1	63.2%
2	TRUE CARE BIOMEDIX

Top Countries Importing Docusate from India

35 destination markets · Ranked by import value

All 35 countries →

Top Countries Importing Docusate from India — Ranked by Import Value
#	Country	Import Value (USD)	Market Share
1	UNITED STATES	$7.8M	84.6%
2	AUSTRALIA	$1.2M	12.9%
3	CANADA	$134.6K	1.5%
4	VENEZUELA	$28.3K	0.3%
5	NEW ZEALAND	$18.7K	0.2%
6	UNITED ARAB EMIRATES	$12.2K	0.1%
7	KENYA	$10.6K	0.1%
8	HONDURAS	$10.4K	0.1%
9	KUWAIT	$7.4K	0.1%
10	GUATEMALA	$3.9K	0.0%

UNITED STATES is India's largest docusate export destination, absorbing 84.6% of total exports worth $7.8M. The top 5 importing countries — UNITED STATES, AUSTRALIA, CANADA, VENEZUELA, NEW ZEALAND — together account for 99.4% of India's total docusate export value. The remaining 30 destination countries collectively receive the other 0.6%, indicating a focused distribution strategy targeting key markets.

Who Supplies Docusate to India?

3 origin countries · Total import value: $408

India imports docusate from 3 countries with a combined import value of $408. The largest supplier is UNITED KINGDOM ($324, 3 shipments), followed by JAPAN and CANADA. All values are from Indian Customs (DGFT) import records.

Countries Supplying Docusate to India — Ranked by Import Value
#	Origin Country	Import Value (USD)	Shipments	Share
1	UNITED KINGDOM	$324	3	79.6%
2	JAPAN	$71	3	17.5%
3	CANADA	$12	1	2.9%

UNITED KINGDOM is the largest supplier of docusate to India, accounting for 79.6% of total import value. Click any country to see detailed supplier and buyer data for that import corridor.

Regulatory Landscape — Docusate

Product-specific regulatory status across FDA, EMA, WHO, and CDSCO · As of March 2026

1FDA & US Market Regulatory Status

In the United States, docusate is recognized as an over-the-counter (OTC) stool softener. The FDA's Final Administrative Order OTC000032, issued in December 2025, lists docusate calcium, docusate potassium, and docusate sodium as approved active ingredients for stool softener laxatives. This classification allows for the marketing of docusate-containing products without the need for an Abbreviated New Drug Application (ANDA), streamlining the regulatory pathway for manufacturers.

Given that docusate is marketed as an OTC product, the FDA does not maintain a specific count of approved ANDAs for this ingredient in the Orange Book. The absence of import alerts or significant regulatory actions against docusate products indicates a stable compliance environment for Indian exporters targeting the U.S. market. The substantial export volume to the United States underscores the importance of adhering to FDA regulations to maintain market access.

2EU & UK Regulatory Framework

In the European Union, docusate-containing products are subject to marketing authorization requirements overseen by the European Medicines Agency (EMA). Manufacturers must demonstrate compliance with EU Good Manufacturing Practice (GMP) standards to obtain and maintain these authorizations. Similarly, in the United Kingdom, the Medicines and Healthcare products Regulatory Agency (MHRA) regulates docusate products. A comprehensive review conducted by the MHRA in September 2020 assessed the benefits and risks of over-the-counter stimulant laxatives, including docusate. The review highlighted concerns about misuse and overuse, particularly among individuals with eating disorders, leading to recommendations for enhanced labeling and risk minimization measures. (gov.uk)

3WHO Essential Medicines & Global Standards

Docusate is included in the World Health Organization's Model List of Essential Medicines, underscoring its significance in global healthcare. The inclusion in the WHO list reflects the medication's established efficacy and safety profile. Additionally, docusate formulations are standardized in various pharmacopoeias, including the United States Pharmacopeia (USP), British Pharmacopoeia (BP), European Pharmacopoeia (EP), and Indian Pharmacopoeia (IP), ensuring consistent quality and therapeutic equivalence across different markets.

4India Regulatory Classification

In India, docusate is classified as a Schedule H drug under the Drugs and Cosmetics Act, requiring a prescription for sale. The Central Drugs Standard Control Organization (CDSCO) oversees its regulation, ensuring compliance with national standards. The National Pharmaceutical Pricing Authority (NPPA) has not imposed a ceiling price on docusate, allowing market-driven pricing. For export purposes, manufacturers must obtain a No Objection Certificate (NOC) from the Directorate General of Foreign Trade (DGFT), confirming compliance with export regulations.

5Patent & Exclusivity Status

Docusate has been available in the pharmaceutical market for several decades, and any original patents have long expired. This expiration has led to a competitive market with multiple generic manufacturers producing docusate formulations, contributing to its widespread availability and affordability.

6Recent Industry Developments

In December 2025, the FDA issued Final Administrative Order OTC000032, which included docusate as an approved active ingredient for OTC stool softener laxatives. This order provides clarity and regulatory certainty for manufacturers and exporters.

In September 2020, the UK's MHRA conducted a comprehensive review of over-the-counter stimulant laxatives, including docusate. The review addressed concerns about misuse and overuse, particularly among individuals with eating disorders, leading to recommendations for enhanced labeling and risk minimization measures. (gov.uk)

These developments highlight the dynamic regulatory environment surrounding docusate, emphasizing the need for manufacturers and exporters to stay informed and compliant with evolving standards to ensure continued market access.

TransData Nexus Research · FDA Orange Book, EMA, WHO Model List, CDSCO/NPPAUpdated Mar 2026

Get Complete Export Intelligence Report

300+ pages · Supplier profiles · Buyer analysis · Price benchmarks · Every shipment record

Free

Global Price Benchmark — Docusate

Retail & reference prices across 9 markets vs. India FOB export price of $12.69/unit

Global Price Benchmark for Docusate across major pharmaceutical markets
Market	Price (USD/unit)	Currency	Reference
United States	$0.08	USD	According to the FDA, docusate sodium is available over-the-counter, and pricing can vary based on brand and retailer.
United Kingdom	$0.07	GBP	As per the NHS Drug Tariff, docusate sodium is listed and reimbursed under the National Health Service.
Germany	$0.07	EUR	The Federal Institute for Drugs and Medical Devices (BfArM) regulates the pricing and availability of docusate sodium in Germany.
Australia	$0.07

Supply Chain Risk Assessment — Docusate

API sourcing, concentration risk, storage requirements, and current alerts

HIGH RISK

1API Sourcing & Raw Material Dependency

Docusate, a widely used stool softener, is primarily manufactured in India, which has established itself as a leading producer of Active Pharmaceutical Ingredients (APIs). However, India's API production is heavily reliant on Key Starting Materials (KSMs) imported from China. This dependency poses a significant risk, as any disruption in the supply of KSMs from China can directly impact India's ability to produce APIs, including Docusate. According to the U.S. Pharmacopeia, 41% of KSMs used in U.S.-approved APIs are solely sourced from China, highlighting the concentration risk in the supply chain.

Recent geopolitical tensions have exacerbated these vulnerabilities. In February 2026, the closure of the Strait of Hormuz—a critical maritime passage—disrupted the transportation of petrochemical feedstocks essential for API synthesis. This disruption led to increased production costs and logistical challenges for pharmaceutical manufacturers in India. The American Chemical Society reported that the halt of naphtha shipments through the strait has caused delays in procurement and production cutbacks in the chemical industry, which are integral to pharmaceutical manufacturing.

2Supplier Concentration & Single-Source Risk

Our proprietary trade data indicates a high concentration among Indian exporters of Docusate. The top five exporters account for 92.0% of total exports, with TRUECARE BIOMEDIX alone contributing 63.2% ($5.9 million) of the $9.3 million total export value. This significant concentration presents a single-source risk, as any operational or financial issues faced by these key suppliers could disrupt the global supply of Docusate.

Access Complete Docusate Trade Intelligence

Shipment-level records, verified supplier contacts, buyer histories, and pricing analytics for all 453 transactions across 35 markets.

Request Demo View Pricing

Frequently Asked Questions — Docusate Exports from India

Data-backed answers sourced from Indian Customs shipping bill records

Who are the top docusate exporters from India?

The leading docusate exporters from India are TRUECARE BIOMEDIX, TRUE CARE BIOMEDIX, CIPLA LIMITED, and 8 others. TRUECARE BIOMEDIX leads with 63.2% market share ($5.9M). The top 5 suppliers together control 92.0% of total export value.

What is the total export value of docusate from India?

The total export value of docusate from India is $9.3M, recorded across 453 shipments from 25 active exporters to 35 countries. The average shipment value is $20.5K.

Which countries import docusate from India?

India exports docusate to 35 countries. The top importing countries are UNITED STATES (84.6%), AUSTRALIA (12.9%), CANADA (1.5%), VENEZUELA (0.3%), NEW ZEALAND (0.2%), which together account for 99.4% of total export value.

What is the HS code for docusate exports from India?

The primary HS code for docusate exports from India is 30049039. This 8-digit classification falls under Chapter 30 (pharmaceutical products) of the Harmonized System and is used by Indian Customs (DGFT) to track and report pharmaceutical export flows.

Official References & Regulatory Resources

Research Methodology & Data Transparency

Suresh Sormare

Verified Author

Pharmaceutical Export-Import Analyst & Trade Intelligence Expert

Suresh Sormare is a pharmaceutical export-import analyst with deep expertise in Indian Customs (DGFT) data, HS code classification, and global pharmaceutical supply chains. His analysis covers 10M+ shipment records across 150+ countries and is used by manufacturers, procurement agencies, and trade consultants worldwide. Suresh specializes in identifying verified suppliers and buyers from customs records, mapping bilateral pharmaceutical trade corridors, analyzing tariff structures and regulatory frameworks across 170+ destination markets, and benchmarking competitive positioning for finished pharmaceutical formulations. His methodology combines granular customs transaction data with regulatory intelligence from FDA, EMA, WHO, CDSCO, and 40+ national drug authorities to deliver actionable trade insights for the pharmaceutical formulations sector.

linkedin.com/in/sureshsormare

Primary Data Source

All trade data is sourced from Indian Customs (DGFT) official shipping bill records — the authoritative government database for India's pharmaceutical trade. Each verified record contains exporter name, consignee (buyer) name, detailed product description, quantity, declared FOB value (USD), port of loading, destination country, and shipment date.

Docusate

Docusate

Top Docusate Exporters from India

Top Countries Importing Docusate from India

Who Supplies Docusate to India?

Quick Facts

Related Gastrointestinal

Related Analysis

Need Details?

Regulatory Landscape — Docusate

1FDA & US Market Regulatory Status

2EU & UK Regulatory Framework

3WHO Essential Medicines & Global Standards

4India Regulatory Classification

5Patent & Exclusivity Status

6Recent Industry Developments

Global Price Benchmark — Docusate

Supply Chain Risk Assessment — Docusate

1API Sourcing & Raw Material Dependency

2Supplier Concentration & Single-Source Risk

Access Complete Docusate Trade Intelligence

Frequently Asked Questions — Docusate Exports from India

Who are the top docusate exporters from India?

What is the total export value of docusate from India?

Which countries import docusate from India?

What is the HS code for docusate exports from India?

Official References & Regulatory Resources

Research Methodology & Data Transparency

Suresh Sormare

Primary Data Source

India Cost Advantage

3Geopolitical & Shipping Disruptions

4Risk Mitigation Recommendations

What is the average price of docusate exports from India?

Which ports handle docusate exports from India?

Why is India a leading exporter of docusate?

What certifications do Indian docusate exporters need?

How many buyers import docusate from India?

What is the market share of the top docusate exporter from India?

Analysis Methodology